Femarelle launches new women’s supplement line in US

Targeted formulas support symptoms before, during and after menopause.

Femarelle is developed from a proprietary extract, DT56a, which has been shown in clinical studies to support healthy management of menopause symptoms. Because the symptoms of estrogen decline vary from ages 40-70+, each product provides a targeted solution with additional ingredients to address the needs of the individual.

“Femarelle is a natural option to relieve the symptoms of menopause,” said Dr Margaret Nachtigall, a founding member of the North American Menopause Society and a noted reproductive endocrinologist. “The inevitable decline in estrogen levels is experienced differently by women at different stages of life, so having three unique products ensures specific symptoms get targeted attention at the right time.”

Backed by 19 published studies in the most prestigious scientific journals, Femarelle® offers compelling, consistent and validated results for women 40 and beyond. Femarelle contains no soy isoflavones, plus each formula is tissue-specific in its mode of action for maximum focused effort and results.